SNPMiner Trials (Home Page)
Report for SNP rs11099592
Developed by Shray Alag, 2020.
SNP Clinical Trial Gene
There is one clinical trial.
Clinical Trials
1 Search for Genetic Basis of Vulvodynia
The purpose of this study is to investigate the possibility of an association between Localized Provoked Vulvodynia (LPV) that is both severe and primary and polymorphic markers/single nucleotide polymorphisms (SNPs) in and around the genes encoding heparanase (HSPE-1), Vanilloid Receptor VR1 (TRPV1), and Nerve Growth Factor (NGF).
NCT01664962 Vulvodynia MeSH:Vulvodynia
Eight polymorphic SNPs in the three different genes suspected to be involved in LPV has been examined as follow: 1. HSPE gene: Four polymorphic SNPs: rs4693608, rs11099592, rs6856901 and rs4364254 that were found to be informative in the Ashkenazi Jewish population 2. TRPV1 gene: Two polymorphic SNPs: rs222747 and rs8065080.
Primary Outcomes
Description: the possibility of an association between Localized Provoked Vulvodynia (LPV) that is both severe and primary and polymorphic markers/single nucleotide polymorphisms (SNPs) in and around the genes encoding heparanase (HSPE-1), Vanilloid Receptor VR1 (TRPV1), and Nerve Growth Factor (NGF).
Measure: Genetic association of Vulvodynia Time: four years